New Alzheimer’s drug could be available next year, but are the risks worth the reward?
Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease.
These are very promising results, although the only data we have at the moment are from the drug manufacturer’s press release.
